21.5 C
New York
Saturday, June 3, 2023

The Question Is Whether To Buy Or Not To Buy Arcutis Biotherapeutics Inc. (NASDAQ: ARQT)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Arcutis Biotherapeutics Inc. (ARQT) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $14.56. The Arcutis Biotherapeutics Inc. has recorded 15,589 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

Arcutis Biotherapeutics Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $14.56 and fluctuated between $14.94 as its day high and $14.54 as its day low. The current market capitalization of Arcutis Biotherapeutics Inc. is $888.45M. A total of 0.84 million shares were traded on the day, compared to an average of 998.64K shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, ARQT has seen 10 BUY and 34 SELL insider trades, representing the acquisition of 157,300 and the disposition of 53,630 shares. Over the last 12 months, there were 27 BUYs and 59 SELLs from insiders. Insiders purchased 478,153 shares during that period but sold 727,155.

In the most recent transaction, Welgus Howard G. sold 8,500 shares of ARQT for 13.97 per share on Apr 17. After the transaction, the Director now owns 165,825 company shares. In a previous transaction on Apr 06, Welgus Howard G. sold 8,500 shares at 12.01 per share. ARQT shares that Director owns now total 165,825.

Among the insiders who sold shares, Watanabe Todd Franklin disposed of 2,435 shares on Mar 06 at a per-share price of $15.26. This resulted in the insider holding 366,657 shares of ARQT after the transaction. In another insider transaction, Burnett Patrick sold 851 shares at $15.26 per share on Mar 06. Company shares held by the insider now total 59,962.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for ARQT in the last 3 months, the mean price target is $50.33 with high estimates of $80.00 and low estimates of $24.00. In terms of 52-week highs and lows, ARQT has a high of $27.40 and a low of $10.05.

As of this writing, ARQT has an earnings estimate of -$1.28 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$1.2 per share and a lower estimate of -$1.43. The company reported an EPS of -$1.89 in the last quarter, which was -13.20% lower than expectations of -$1.67.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ARQT’s latest balance sheet shows that the firm has $387.06M in Cash & Short Term Investments as of fiscal 2021. There were $77.56M in debt and $33.33M in liabilities at the time. Its Book Value Per Share was $3.43, while its Total Shareholder’s Equity was $297.68M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARQT is Buy with a score of 4.86.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles